Clinical trials: Reversible Cerebral Vasoconstriction Syndrome
Reversible Cerebral Vasoconstriction Syndrome
Perfusion MRI in Reversible Cerebral Vasoconstriction Syndrome
This study aims to quantify perfusion, assess arterial vasoconstriction, and confirm reversibility using 3T ASL-MRI and MRA in 10 patients with suspected RCVS.
- Trial name
- NCT02756416
- Testing
- MRI brain, ASL-MRI brain, MRA brain
- Where
- United Kingdom
- Volunteers
- 10 people
- Sponsor
- University of Nottingham
Reversible Cerebral Vasoconstriction Syndrome
RCVS: The Rational Approach to Diagnosis and Treatment
This is a randomized clinical trial of short-acting nimodipine versus twice daily extended release verapamil to treat patients presenting with Reversible Cerebral Vasoconstriction Syndrome (RCVS).
- Trial name
- NCT03150524
- Testing
- TCD- cerebral blood flow velocities, Headache pain score, Neurological examination
- Where
- 2 sites in United States
- Sponsor
- Johns Hopkins University
Reversible Cerebral Vasoconstriction Syndrome, Varicella-zoster Virus Infection
Reversible Cerebral Vasoconstriction Syndrome and Varicella Zoster Virus
Among patients with thunderclap headache who were admitted to the four participating hospitals, who has diffuse segmental vasoconstriction on CT angiography or MR angiography will be eligible for the study.
- Trial name
- RCVS&VZV (NCT03509701)
- Testing
- VZV-specific antibody response from blood
- Where
- South Korea
- Volunteers
- 40 people
- Sponsor
- Asan Medical Center
Reversible Cerebral Vasoconstriction Syndrome
Triggers And Risk Factors to Develop a Reversible Cerebral Vasoconstriction Syndrome
This study will be the first to evaluate the role played by potential precipitating factors and risk factors in Reversible Cerebral Vasoconstriction Syndrome (RCVS) through of prospective selection of carefully characterised…
- Trial name
- TARDIS (NCT04179383)
- Testing
- Constitution of a biobank
- Where
- France
- Volunteers
- 225 people, healthy volunteers welcome
- Sponsor
- University Hospital, Montpellier
Reversible Cerebrovascular Vasoconstriction Syndrome
Retinal Patterns in Reversible Cerebral Vasoconstriction Syndrome
Reversible cerebral vasoconstriction syndrome (RCVS) is a clinico radiological entity characterized by severe headaches (associated or not with neurological complications) during one to 3 weeks, associated with a characteristic…
- Trial name
- SVC-2R (NCT03204110)
- Where
- France
- Volunteers
- 23 people
- Sponsor
- Assistance Publique - Hôpitaux de Paris
Transient Global Amnesia, Reversible Vasoconstriction Syndrome
Reversible Cerebral Vasoconstriction Syndrome With Concomitant Transient Global Amnesia
Reversible cerebral vasoconstriction syndrome (RCVS) is characterized by severe, unusual headaches associated with multifocal segmental vasoconstriction of the intracerebral arteries.
- Trial name
- NCT03739008
- Where
- France
- Volunteers
- 3 people
- Sponsor
- University Hospital, Montpellier
Stroke (CVA) or TIA, Headache, Migraine
Onabotulinum Toxin A (Botox) for the Treatment of Persistent Post-Stroke and Vascular Headache
Post stroke headache occurs in approximately 10-23% of all stroke patients. Its onset is shortly after experiencing a stroke, or stroke like event, and persists for at least three months.
- Conditions
- Stroke (CVA) or TIA, Headache, Migraine, Botulinum Toxins, Type A, Cerebral Venous Sinus Thrombosis
- Trial name
- NCT04580238
- Testing
- Botox 200 UNT Injection, Non Botox based Standard of Care Treatments for Headache/Migraine
- Where
- Canada
- Sponsor
- University of Alberta
Reversible Cerebral Vasoconstriction Syndrome
Endothelial Dysfunction in Reversible Cerebral Vasoconstriction Syndrome
Reversible Cerebral Vasoconstriction Syndrome (RCVS) is a syndrome described at the end of the 20th century. Generally, it has a benign course.
- Trial name
- DESS (NCT04463212)
- Where
- France
- Volunteers
- 62 people, healthy volunteers welcome
- Sponsor
- Nantes University Hospital
Cerebrovascular Disease, Ischemic Stroke
Florida Cerebrovascular Disease Biorepository and Genomics Center
The purpose of this study is to create a state-wide biorepository and resource center for cerebrovascular diseases in Florida, which will include collecting medical history information and blood from subjects affected by…
- Conditions
- Cerebrovascular Disease, Ischemic Stroke, Transient Ischemic Attack, Intracerebral Hemorrhage
- Trial name
- NCT05491980
- Where
- United States
- Volunteers
- 72 people
- Sponsor
- Mayo Clinic